A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
Status:
Not yet recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1b/2 platform study framework to evaluate the safety and efficacy of
investigational candidate(s) and their combinations as potential treatments for adults with
chronic HBV infection.